Specialty Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Formulation type (oral, parenteral, topical, others), Therapeutic Application(oncology, inflammatory conditions, multiple sclerosis, hepatitis C,), Distributional Channel(specialty pharmacy, retail pharmacy, hospital pharmacy, others).

Report Code: TIPRE00021203 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION
:
Specialty generics are generic versions of specialty drugs once they get off-patent. Specialty generics are low-cost oral or injectable medications used to treat complex chronic conditions such as cancer, HIV, Hepatitis, multiple sclerosis. They are often biologics (derived from living cells) injectable or infused. According to U.S. FDA, generic drugs cost 80% to 85% lower as compared to branded drugs as they don't require costly development and marketing costs.

MARKET DYNAMICS
:
The Specialty Generics Market is estimated to accelerate growth in the forecast period owing to driving factors such as the introduction of cost-effective drugs for the treatment of multiple sclerosis, cancer, and other infectious diseases, rise in the number of an off-patent specialty drug, early patent expirations are expected to boost the entry of new generics.

MARKET SCOPE

The "Specialty Generics Market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Specialty Generics Market with detailed market segmentation by of Formulation type, Therapeutic Application, Distributional Channel. The Specialty Generics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Specialty Generics Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Specialty Generics Market is segmented on the basis of formulation type, therapeutic application, distributional channel. Based on formulation types, the market is segmented as oral, parenteral, topical, others. Based on therapeutic application , the market is segmented as oncology, inflammatory conditions, multiple sclerosis, hepatitis C, others. Based on distributional channel, the market is segmented as specialty pharmacy, retail pharmacy, hospital pharmacy, others

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Specialty Generics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Specialty Generics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Specialty Generics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Specialty Generics Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Specialty Generics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Specialty Generics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Specialty Generics Market in the global market. Below mentioned is the list of few companies engaged in the Inositol Market.

The report also includes the profiles of key players in Specialty Generics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Valeant Pharmaceuticals International, Inc.,
  •   Novartis
  •   Pfizer Inc.,
  •   Turing Pharmaceuticals,
  •   Teva Pharmaceutical Ltd.,
  •   Mylan N.V.,
  •   Akorn, Inc.,
  •   Mallinckrodt
  •   Lupin Pharmaceuticals
  •   Sandoz

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Specialty Generics Market - By Formulation type
1.3.2 Specialty Generics Market - By Therapeutic Application
1.3.3 Specialty Generics Market - By Distributional Channel
1.3.4 Specialty Generics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SPECIALTY GENERICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SPECIALTY GENERICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SPECIALTY GENERICS MARKET - GLOBAL MARKET ANALYSIS
6.1. SPECIALTY GENERICS - GLOBAL MARKET OVERVIEW
6.2. SPECIALTY GENERICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SPECIALTY GENERICS MARKET - REVENUE AND FORECASTS TO 2028 - FORMULATION TYPE
7.1. OVERVIEW
7.2. FORMULATION TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORAL
7.3.1. Overview
7.3.2. Oral Market Forecast and Analysis
7.4. PARENTERAL
7.4.1. Overview
7.4.2. Parenteral Market Forecast and Analysis
7.5. TOPICAL
7.5.1. Overview
7.5.2. Topical Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. SPECIALTY GENERICS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTIC APPLICATION
8.1. OVERVIEW
8.2. THERAPEUTIC APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. INFLAMMATORY CONDITION
8.4.1. Overview
8.4.2. Inflammatory condition Market Forecast and Analysis
8.5. MULTIPLE SCLEROSIS
8.5.1. Overview
8.5.2. Multiple sclerosis Market Forecast and Analysis
8.6. HEPATITIS C
8.6.1. Overview
8.6.2. Hepatitis C Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. SPECIALTY GENERICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTIONAL CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTIONAL CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. SPECIALTY PHARMACY
9.3.1. Overview
9.3.2. Specialty pharmacy Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. Retail pharmacy Market Forecast and Analysis
9.5. HOSPITAL PHARMACY
9.5.1. Overview
9.5.2. Hospital pharmacy Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. others Market Forecast and Analysis
10. SPECIALTY GENERICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Specialty Generics Market Overview
10.1.2 North America Specialty Generics Market Forecasts and Analysis
10.1.3 North America Specialty Generics Market Forecasts and Analysis - By Formulation type
10.1.4 North America Specialty Generics Market Forecasts and Analysis - By Therapeutic Application
10.1.5 North America Specialty Generics Market Forecasts and Analysis - By Distributional Channel
10.1.6 North America Specialty Generics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Specialty Generics Market
10.1.6.1.1 United States Specialty Generics Market by Formulation type
10.1.6.1.2 United States Specialty Generics Market by Therapeutic Application
10.1.6.1.3 United States Specialty Generics Market by Distributional Channel
10.1.6.2 Canada Specialty Generics Market
10.1.6.2.1 Canada Specialty Generics Market by Formulation type
10.1.6.2.2 Canada Specialty Generics Market by Therapeutic Application
10.1.6.2.3 Canada Specialty Generics Market by Distributional Channel
10.1.6.3 Mexico Specialty Generics Market
10.1.6.3.1 Mexico Specialty Generics Market by Formulation type
10.1.6.3.2 Mexico Specialty Generics Market by Therapeutic Application
10.1.6.3.3 Mexico Specialty Generics Market by Distributional Channel
10.2. EUROPE
10.2.1 Europe Specialty Generics Market Overview
10.2.2 Europe Specialty Generics Market Forecasts and Analysis
10.2.3 Europe Specialty Generics Market Forecasts and Analysis - By Formulation type
10.2.4 Europe Specialty Generics Market Forecasts and Analysis - By Therapeutic Application
10.2.5 Europe Specialty Generics Market Forecasts and Analysis - By Distributional Channel
10.2.6 Europe Specialty Generics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Specialty Generics Market
10.2.6.1.1 Germany Specialty Generics Market by Formulation type
10.2.6.1.2 Germany Specialty Generics Market by Therapeutic Application
10.2.6.1.3 Germany Specialty Generics Market by Distributional Channel
10.2.6.2 France Specialty Generics Market
10.2.6.2.1 France Specialty Generics Market by Formulation type
10.2.6.2.2 France Specialty Generics Market by Therapeutic Application
10.2.6.2.3 France Specialty Generics Market by Distributional Channel
10.2.6.3 Italy Specialty Generics Market
10.2.6.3.1 Italy Specialty Generics Market by Formulation type
10.2.6.3.2 Italy Specialty Generics Market by Therapeutic Application
10.2.6.3.3 Italy Specialty Generics Market by Distributional Channel
10.2.6.4 Spain Specialty Generics Market
10.2.6.4.1 Spain Specialty Generics Market by Formulation type
10.2.6.4.2 Spain Specialty Generics Market by Therapeutic Application
10.2.6.4.3 Spain Specialty Generics Market by Distributional Channel
10.2.6.5 United Kingdom Specialty Generics Market
10.2.6.5.1 United Kingdom Specialty Generics Market by Formulation type
10.2.6.5.2 United Kingdom Specialty Generics Market by Therapeutic Application
10.2.6.5.3 United Kingdom Specialty Generics Market by Distributional Channel
10.2.6.6 Rest of Europe Specialty Generics Market
10.2.6.6.1 Rest of Europe Specialty Generics Market by Formulation type
10.2.6.6.2 Rest of Europe Specialty Generics Market by Therapeutic Application
10.2.6.6.3 Rest of Europe Specialty Generics Market by Distributional Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Specialty Generics Market Overview
10.3.2 Asia-Pacific Specialty Generics Market Forecasts and Analysis
10.3.3 Asia-Pacific Specialty Generics Market Forecasts and Analysis - By Formulation type
10.3.4 Asia-Pacific Specialty Generics Market Forecasts and Analysis - By Therapeutic Application
10.3.5 Asia-Pacific Specialty Generics Market Forecasts and Analysis - By Distributional Channel
10.3.6 Asia-Pacific Specialty Generics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Specialty Generics Market
10.3.6.1.1 Australia Specialty Generics Market by Formulation type
10.3.6.1.2 Australia Specialty Generics Market by Therapeutic Application
10.3.6.1.3 Australia Specialty Generics Market by Distributional Channel
10.3.6.2 China Specialty Generics Market
10.3.6.2.1 China Specialty Generics Market by Formulation type
10.3.6.2.2 China Specialty Generics Market by Therapeutic Application
10.3.6.2.3 China Specialty Generics Market by Distributional Channel
10.3.6.3 India Specialty Generics Market
10.3.6.3.1 India Specialty Generics Market by Formulation type
10.3.6.3.2 India Specialty Generics Market by Therapeutic Application
10.3.6.3.3 India Specialty Generics Market by Distributional Channel
10.3.6.4 Japan Specialty Generics Market
10.3.6.4.1 Japan Specialty Generics Market by Formulation type
10.3.6.4.2 Japan Specialty Generics Market by Therapeutic Application
10.3.6.4.3 Japan Specialty Generics Market by Distributional Channel
10.3.6.5 South Korea Specialty Generics Market
10.3.6.5.1 South Korea Specialty Generics Market by Formulation type
10.3.6.5.2 South Korea Specialty Generics Market by Therapeutic Application
10.3.6.5.3 South Korea Specialty Generics Market by Distributional Channel
10.3.6.6 Rest of Asia-Pacific Specialty Generics Market
10.3.6.6.1 Rest of Asia-Pacific Specialty Generics Market by Formulation type
10.3.6.6.2 Rest of Asia-Pacific Specialty Generics Market by Therapeutic Application
10.3.6.6.3 Rest of Asia-Pacific Specialty Generics Market by Distributional Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Specialty Generics Market Overview
10.4.2 Middle East and Africa Specialty Generics Market Forecasts and Analysis
10.4.3 Middle East and Africa Specialty Generics Market Forecasts and Analysis - By Formulation type
10.4.4 Middle East and Africa Specialty Generics Market Forecasts and Analysis - By Therapeutic Application
10.4.5 Middle East and Africa Specialty Generics Market Forecasts and Analysis - By Distributional Channel
10.4.6 Middle East and Africa Specialty Generics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Specialty Generics Market
10.4.6.1.1 South Africa Specialty Generics Market by Formulation type
10.4.6.1.2 South Africa Specialty Generics Market by Therapeutic Application
10.4.6.1.3 South Africa Specialty Generics Market by Distributional Channel
10.4.6.2 Saudi Arabia Specialty Generics Market
10.4.6.2.1 Saudi Arabia Specialty Generics Market by Formulation type
10.4.6.2.2 Saudi Arabia Specialty Generics Market by Therapeutic Application
10.4.6.2.3 Saudi Arabia Specialty Generics Market by Distributional Channel
10.4.6.3 U.A.E Specialty Generics Market
10.4.6.3.1 U.A.E Specialty Generics Market by Formulation type
10.4.6.3.2 U.A.E Specialty Generics Market by Therapeutic Application
10.4.6.3.3 U.A.E Specialty Generics Market by Distributional Channel
10.4.6.4 Rest of Middle East and Africa Specialty Generics Market
10.4.6.4.1 Rest of Middle East and Africa Specialty Generics Market by Formulation type
10.4.6.4.2 Rest of Middle East and Africa Specialty Generics Market by Therapeutic Application
10.4.6.4.3 Rest of Middle East and Africa Specialty Generics Market by Distributional Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Specialty Generics Market Overview
10.5.2 South and Central America Specialty Generics Market Forecasts and Analysis
10.5.3 South and Central America Specialty Generics Market Forecasts and Analysis - By Formulation type
10.5.4 South and Central America Specialty Generics Market Forecasts and Analysis - By Therapeutic Application
10.5.5 South and Central America Specialty Generics Market Forecasts and Analysis - By Distributional Channel
10.5.6 South and Central America Specialty Generics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Specialty Generics Market
10.5.6.1.1 Brazil Specialty Generics Market by Formulation type
10.5.6.1.2 Brazil Specialty Generics Market by Therapeutic Application
10.5.6.1.3 Brazil Specialty Generics Market by Distributional Channel
10.5.6.2 Argentina Specialty Generics Market
10.5.6.2.1 Argentina Specialty Generics Market by Formulation type
10.5.6.2.2 Argentina Specialty Generics Market by Therapeutic Application
10.5.6.2.3 Argentina Specialty Generics Market by Distributional Channel
10.5.6.3 Rest of South and Central America Specialty Generics Market
10.5.6.3.1 Rest of South and Central America Specialty Generics Market by Formulation type
10.5.6.3.2 Rest of South and Central America Specialty Generics Market by Therapeutic Application
10.5.6.3.3 Rest of South and Central America Specialty Generics Market by Distributional Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SPECIALTY GENERICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. SPECIALTY GENERICS MARKET, KEY COMPANY PROFILES
13.1. VALEANT PHARMACEUTICALS INTERNATIONAL, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. NOVARTIS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TURING PHARMACEUTICALS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. TEVA PHARMACEUTICAL LTD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MYLAN NV
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. AKORN, INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MALLINCKRODT
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. LUPIN PHARMACEUTICALS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SANDOZ
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERM
The List of Companies

1. Valeant Pharmaceuticals International, Inc.,
2. Novartis
3. Pfizer Inc.,
4. Turing Pharmaceuticals,
5. Teva Pharmaceutical Ltd.,
6. Mylan N.V.,
7. Akorn, Inc.,
8. Mallinckrodt
9. Lupin Pharmaceuticals
10. Sandoz
11. Sun Pharmaceuticals
12. Amneal Pharmaceuticals
13. Par Pharmaceuticals
14. Endo Pharmaceuticals
15. Actavis
TIPRE00021203
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking